Institute of Biomedical Research Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRES research report →
About the company
Institute of Biomedical Research Corp. (MRES) is a dedicated provider of comprehensive biomedical research and analytical services, operating both within Montenegro and across international markets. The company's core activities encompass fundamental scientific investigation and robust research and development initiatives for new biomedical products, advanced technologies, and innovative diagnostic methods, including experimental medical treatments.
- CEO
- Drasko D. Pekovic
- IPO
- 2004
- Employees
- 7
- HQ
- Podgorica, ME
Price Chart
- Market Cap
- $2.54M
- P/E
- 1.18
- P/S
- 91.76
- P/B
- -4.69
- EV/EBITDA
- -8.25
- Div Yield
- 0.00%
- Gross Margin
- -5.42%
- Op Margin
- -1106.46%
- Net Margin
- -8882.84%
- ROE
- -1825.86%
- ROIC
- 61.79%
- Revenue
- $27.71K · -44.01%
- Net Income
- $-2,461,081 · -288.97%
- EPS
- $0.00 · 550.00%
- Op Income
- $-306,556
- FCF YoY
- 0.00%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.61
- Avg Volume
- 1.27M
Get TickerSpark's AI analysis on MRES
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MRES coverage
Recent articles, reports, and earnings notes.
No research on MRES yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MRES report →Similar companies
Peers in the same neighborhood.